Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04026555 · ClinicalTrials.gov registry record · NA

Realtime Streaming Clinical Use Engine for Medical Escalation

A NA study of Clinical Deterioration and Hospital Medicine, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
2,780
Enrollment target
1
Study location

NCT04026555: Completed NA study of Clinical Deterioration and Hospital Medicine, sponsored by Icahn School of Medicine at Mount Sinai.

NCT04026555 is a NA study of Clinical Deterioration and Hospital Medicine that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 2,780 participants, below the 13,600-participant average among 3 other Clinical Deterioration trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04026555, a NA study of Clinical Deterioration and Hospital Medicine, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
2,780 participants
Enrollment target
1
Study location

Study Summary

The escalation of care for patients in a hospitalized setting between nurse practitioner managed services, teaching services, step-down units, and intensive care units is critical for appropriate care for any patient. Often such "triggers" for escalation are initiated based on the nursing evaluation of the patient, followed by physician history and physical exam, then augmented based on laboratory values. These "triggers" can enhance the care of patients without increasing the workload of responder teams. One of the goals in hospital medicine is the earlier identification of patients that require an escalation of care. The study team developed a model through a retrospective analysis of the historical data from the Mount Sinai Data Warehouse (MSDW), which can provide machine learning based triggers for escalation of care (Approved by: IRB-18-00581). This model is called "Medical Early Warning Score ++" (MEWS ++). This IRB seeks to prospectively validate the developed model through a pragmatic clinical trial of using these alerts to trigger an evaluation for appropriateness of escalation of care on two general inpatients wards, one medical and one surgical. These alerts will not change the standard of care. They will simply suggest to the care team that the patient should be further evaluated without specifying a subsequent specific course of action. In other words, these alerts in themselves does not designate any change to the care provider's clinical standard of care. The study team estimates that this study would require the evaluation of \~ 18380 bed movements and approximately 30 months to complete, based on the rate of escalation of care and rate of bed movements in the selected units.

Primary Outcome

Rate of escalation of care from floor to Stepdown, Telemetry, ICU, per 1,000 patient bed days.

Interventions

  • OTHER MEWS++ Monitoring
  • OTHER Predictor Score

Study Locations (1)

New York

  • Mount Sinai Hospital - New York

Trial Details

FieldValue
Enrollment Target 2,780 participants
Start Date 2019-06-18
Est. Completion 2020-03-19
Phase NA

What the finished NCT04026555 record still lists

NCT04026555 is an interventional study that assigns participants to a tested intervention. Its 2,780 participants enrollment target places it among the larger protocols in the corpus, below the 13,600-participant average among 3 other Clinical Deterioration trials with a reported enrollment target (80% lower).

The record links to 3 conditions, with Clinical Deterioration appearing as the primary indexed condition, and to 2 interventions - of which MEWS++ Monitoring is the first listed.

NCT04026555 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04026555 about?

NCT04026555 is a clinical study titled "Realtime Streaming Clinical Use Engine for Medical Escalation". The escalation of care for patients in a hospitalized setting between nurse practitioner managed services, teaching services, step-down units, and intensive care units is critical for appropriate care for any patient. Often such "triggers" for escalation are initiated based on the nursing evaluation...

What is the current status of trial NCT04026555?

This trial is currently completed. It is a NA study. The enrollment target is 2,780 participants. The study started on 2019-06-18. Estimated completion is 2020-03-19.

What conditions does trial NCT04026555 study?

This clinical trial studies the following conditions: Clinical Deterioration, Hospital Medicine, Monitoring, Physiologic.

What interventions are being tested in trial NCT04026555?

The interventions under investigation include: MEWS++ Monitoring (OTHER), Predictor Score (OTHER).

Who is sponsoring clinical trial NCT04026555?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04026555 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Clinical Deterioration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05443737 · 2,800 participants · Phase 3

    Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients

  • NCT05899439 · 2,800 participants

    Immune Function and the Progression to T1D

  • NCT06089109 · 2,800 participants · NA

    Creating VIP Corps to Reduce Maternal Deaths

  • NCT06345339 · 2,800 participants · Phase 2

    A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04026555, the US trial registry maintained by the National Library of Medicine. NCT04026555 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.